State of the Biosciences Industry – Perspectives from Area Leaders
Michigan’s biosciences industry, and especially the local Ann Arbor region, has evolved strongly in recent years. This is thanks to a health-care industry desperate for cost-saving innovation, as well as a supportive ecosystem with great research universities, skilled talent, and focus on commercialization. Industry leaders will talk about their companies’ growth and what it’ll take to ensure an even brighter future for the state’s bio-industry.
 
Panelists
 
Stephen Rapundalo, PhD, President and CEO, MichBio

Tim Mayleben, President and CEO, Esperion Therapeutics

Scott Merz, President and CEO, MC3 Cardiopulmonary